Dr. Elly Riser, MD, MPH

Dr. Riser practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Riser's NPI, 1811428709, was assigned on March 23, 2017. Dr. Riser graduated from University Of Washington School Of Medicine in 2017. Dr. Riser holds Vermont license 042-0014879.

Dr. Riser's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Riser's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Riser is also affiliated with Champlain Valley Physicians Hospital. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Riser to 1 more hospital, 2 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Riser practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Riser's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Riser is licensed in Vermont.

CMS data shows 508 Medicare services from Dr. Riser across 4 procedure codes in 2024, for 215 Medicare patients. Medicare paid $42,354 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 215 Medicare patients who saw Dr. Riser in 2024. The largest group is 75 to 84, with 66 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Riser's median patient age at 73, with 52% women.

In 2024, Dr. Riser wrote 66 Medicare Part D claims for 31 patients. 83% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $370 in total drug cost. In 2019, CMS named 32 claims across 2 drugs.

Dr. Riser accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Riser, published from 2021 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Opioid-Related Disorders, Buprenorphine and Education, Medical, Undergraduate. Dr. Riser's most frequent co-authors are John Ross Brooklyn, MD, Kyle G. Crooker, MD and Jean M. Dejace.

Dr. Riser graduated from University Of Washington School Of Medicine in 2017.